Market Value636,276,129
Total Holdings46
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACET / Adicet Bio, Inc.
SLNCF / Silence Therapeutics plc
PSTX / Poseida Therapeutics, Inc.
JSPR / Jasper Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
AKRO / Akero Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
RGLS / Regulus Therapeutics Inc.
MRSN / Mersana Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
ANNX / Annexon, Inc.
TSHA / Taysha Gene Therapies, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
INSM / Insmed Incorporated Call
VINC / Vincerx Pharma, Inc.
ALLO / Allogene Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
SANA / Sana Biotechnology, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
CYTK / Cytokinetics, Incorporated
ALPN / Alpine Immune Sciences, Inc.
GLYC / GlycoMimetics, Inc.
ISR / Perspective Therapeutics Inc
APLS / Apellis Pharmaceuticals, Inc.
HLXB / Helix Acquisition Corp. II
PEPG / PepGen Inc.
VRDN / Viridian Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
ALVR / AlloVir, Inc.
DYN / Dyne Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
CYBN / Cybin Inc.
CATX / Perspective Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
MLYS / Mineralys Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
RAPT / RAPT Therapeutics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
TNYA / Tenaya Therapeutics, Inc.
NKTX / Nkarta, Inc.
ANTX / AN2 Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
FATE / Fate Therapeutics, Inc.
ATYR / aTyr Pharma, Inc.
GOSS / Gossamer Bio, Inc.
MNMD / Mind Medicine (MindMed) Inc.
AVBP / ArriVent BioPharma, Inc.
VERU / Veru Inc.
ELEV / Elevation Oncology, Inc.
DNTH / Dianthus Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc. Call
CRBP / Corbus Pharmaceuticals Holdings, Inc.
AVTE / Aerovate Therapeutics, Inc.